NCT06298890 The Pattern of Dry Eye Disease After Cataract Surgery
| NCT ID | NCT06298890 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Lithuanian University of Health Sciences |
| Condition | Dry Eye Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2024-03 |
| Primary Completion | 2026-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2024-03 with a primary completion date of 2026-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study is designed to explore dry eye disease (DED) pattern: ocular surface, corneal morphological changes, patients' subjective assessment of DED and their correlations with ocular surface inflammation, pain biomarkers after cataract surgery according to ocular surface lubrication with artificial tears during long-term follow-up.
Eligibility Criteria
Inclusion Criteria: * Cataract patients from 50 to 90 years old who underwent uncomplicated phacoemulsification performed by one (and same) experienced surgeon. * Patients with no underlying ocular surface diseases (keratitis, keratoconjunctivitis and others). * Patients who previously did not undergo any ophthalmic surgery. Exclusion Criteria: * Patient expressed his wish to not participate in the study or discontinue it when already enrolled. * Severe dry eye disease diagnosed with OSDI/DEQ-5 and at least one of the following tests: TBUT less than 10 seconds, tear osmolarity higher than 308 mOsm/l or positive corneal staining. * Glaucoma. * Diabetes mellitus. * Systemic connective tissue disease, autoimmune disease. * Neurologic conditions including stroke, Bell's palsy, Parkinson's, trigeminal nerve dysfunction. * Patients who underwent refractive surgery (LASIK or PRK). * Contact lens users. * One or more of the following concomitant medications: psychiatric medicines, antihistamin
Frequently Asked Questions
Who can join the NCT06298890 clinical trial?
This trial is open to participants of all sexes, aged 50 Years or older, up to 90 Years, studying Dry Eye Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06298890 currently recruiting?
Yes, NCT06298890 is actively recruiting participants. Visit ClinicalTrials.gov or contact Lithuanian University of Health Sciences to inquire about joining.
Where is the NCT06298890 trial being conducted?
This trial is being conducted at Kaunas, Lithuania.
Who is sponsoring the NCT06298890 clinical trial?
NCT06298890 is sponsored by Lithuanian University of Health Sciences. The trial plans to enroll 100 participants.